Cargando…

Enhancement parameters of contrast-enhanced computed tomography for pancreatic ductal adenocarcinoma: Correlation with pathologic grading

BACKGROUND: Pancreatic ductal adenocarcinoma (PDA) is a malignancy with a high mortality rate and short survival time. The conventional computed tomography (CT) has been worldwide used as a modality for diagnosis of PDA, as CT enhancement pattern has been thought to be related to tumor angiogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Woorim, Kim, Young Chul, Min, Seon Jeong, Lee, Sang Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403799/ https://www.ncbi.nlm.nih.gov/pubmed/32821076 http://dx.doi.org/10.3748/wjg.v26.i28.4151

Ejemplares similares

Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis
por: Yang, Jie, et al.
Publicado: (2023)

Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography
por: Kim, Jong Hyeon, et al.
Publicado: (2017)

Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography
por: Ren, Shuai, et al.
Publicado: (2019)

Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography
por: Ren, Shuai, et al.
Publicado: (2019)

Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma
por: Cen, Chunyuan, et al.
Publicado: (2023)

Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma
por: Cao, Bi-Yang, et al.
Publicado: (2023)

Pancreatic Ductal Adenocarcinoma: The Characteristics of Contrast-Enhanced Ultrasound Are Correlated with the Hypoxic Microenvironment
por: Wang, Lan, et al.
Publicado: (2023)

Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasound
por: Jia, Wan-Ying, et al.
Publicado: (2023)

Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability
por: Shi, Hao-Jun, et al.
Publicado: (2016)

Multiphase convolutional dense network for the classification of focal liver lesions on dynamic contrast-enhanced computed tomography
por: Cao, Su-E, et al.
Publicado: (2020)

Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma
por: Shin, Dong Woo, et al.
Publicado: (2022)

Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
por: Li, Yan, et al.
Publicado: (2022)

Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States
por: Lew, Daniel, et al.
Publicado: (2022)

Diagnostic performance of abbreviated gadoxetic acid-enhanced magnetic resonance protocols with contrast-enhanced computed tomography for detection of colorectal liver metastases
por: Ozaki, Kumi, et al.
Publicado: (2022)

Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma
por: Hong, Sarang, et al.
Publicado: (2021)

Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection
por: Zhang, Li-Peng, et al.
Publicado: (2020)

Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study
por: He, Yong-Gang, et al.
Publicado: (2022)

Regional differences in islet amyloid deposition in the residual pancreas with new-onset diabetes secondary to pancreatic ductal adenocarcinoma
por: Wang, Rui, et al.
Publicado: (2023)

Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
por: Deng, Peng-Zhan, et al.
Publicado: (2022)

Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature
por: Lovecek, Martin, et al.
Publicado: (2017)

Comparison of Multiple Radiomics Models for Identifying Histological Grade of Pancreatic Ductal Adenocarcinoma Preoperatively Based on Multiphasic Contrast-Enhanced Computed Tomography: A Two-Center Study in Southwest China
por: Liao, Hongfan, et al.
Publicado: (2022)

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019)

Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound
por: Lu, Xiu-Yun, et al.
Publicado: (2022)

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer
por: Gao, Jian-Feng, et al.
Publicado: (2022)

Instant evaluation of contrast enhanced endoscopic ultrasound helps to differentiate various solid pancreatic lesions in daily routine
por: Kannengiesser, Klaus, et al.
Publicado: (2019)

Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis
por: Tong, Tong, et al.
Publicado: (2022)

Combination of preoperative fibrinogen and D-dimer as a prognostic indicator in pancreatic ductal adenocarcinoma patients undergoing R0 resection
por: Zhang, Li-Peng, et al.
Publicado: (2021)

Contrast-enhanced ultrasound imaging for intestinal lymphoma
por: Cui, Ning-Yi, et al.
Publicado: (2021)

Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
por: Goto, Shintaro, et al.
Publicado: (2023)

Para-aortic lymph node involvement should not be a contraindication to resection of pancreatic ductal adenocarcinoma
por: Pande, Rupaly, et al.
Publicado: (2022)

Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Measuring Perfusion in Pancreatic Ductal Adenocarcinoma and Different Tumor Grade: A Preliminary Single Center Study
por: Zaborienė, Inga, et al.
Publicado: (2023)

New Morphological Features for Grading Pancreatic Ductal Adenocarcinomas
por: Song, Jae-Won, et al.
Publicado: (2013)

Prognostic value of pretreatment contrast-enhanced computed tomography in esophageal neuroendocrine carcinoma: A multi-center follow-up study
por: Zhou, Yue, et al.
Publicado: (2020)

Contrast-enhanced multidetector computed tomography features and histogram analysis can differentiate ameloblastomas from central giant cell granulomas
por: Ghosh, Adarsh, et al.
Publicado: (2022)

Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection
por: Li, Shu-Qun, et al.
Publicado: (2023)

Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images
por: Ren, Shuai, et al.
Publicado: (2019)

Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinoma
por: Wang, Nan, et al.
Publicado: (2023)

Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study
por: Li, Ke, et al.
Publicado: (2020)

Non-contrast-enhanced CT texture analysis of primary and metastatic pancreatic ductal adenocarcinomas: value in assessment of histopathological grade and differences between primary and metastatic lesions
por: Janisch, Michael, et al.
Publicado: (2022)

Prognostic Predicting Role of Contrast-Enhanced Computed Tomography for Locally Advanced Pancreatic Adenocarcinoma
por: Cheng, Chien-shan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j67i1u8h1ko38bk6jqcbu2qp8o